Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen: Oct 27, 2006

Premium
Qiagen this week released three new RNAi related products.
 
The first is the FlexiPlate siRNA, a line of 96-well plates in 0.1-nmol, 0.25-nmol, and 1-nmol scales for use with human or mouse target genes.
 
SiRNAs and controls, Qiagen said, can be selected and arranged on the plates using a Web-based interface.
 
The company has also released the HP OnGuard siRNA design algorithm.
 
The algorithm incorporates a neural-network algorithm and proprietary homology analysis, in addition to other new features including 3' UTR/seed region analysis, SNP avoidance, and interferon motif avoidance, Qiagen said.
 
Lastly, Qiagen introduced the Human Druggable Genome siRNA set 3.0, which targets more than 7,000 genes of therapeutic value. SiRNAs are available through the set either individually or in pools.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.